Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blinded, Parallel Group Comparison Study of the Safety and Efficacy of UHE-103 in Subjects With Moccasin-Type Tinea Pedis

NCT03897257 is registered in ClinicalTrials.gov with Therapeutics, Inc. as lead sponsor.

NCT NCT03897257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03897257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blinded, Parallel Group Comparison Study of the Safety and Efficacy of UHE-103 in Subjects With Moccasin-Type Tinea Pedis
Lead sponsor
Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 15, 2019
Completion date
May 5, 2020
Enrollment
240 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

tinea pedis